ScholarIQanswers from OpenAlex

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy

PaperCitations, authors & open-access status

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy have?

ScholarIQcitation count

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy has 101 citations in the OpenAlex counts ScholarIQ stores.

When was Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy published?

ScholarIQyear

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy has 2010 year in the ScholarIQ index.

What is the open-access status of Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy?

ScholarIQoa status

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy has green oa status in the ScholarIQ index.

What is the DOI of Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy?

ScholarIQdoi

The DOI for Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy is on the source record.

What is the PMID of Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy?

ScholarIQpmid

The PMID for Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy is on the source record.

What is the OpenAlex record for Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy?

ScholarIQopenalex

The OpenAlex for Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial